The Alfred Mann Foundation announced that U.S. Marine Staff Sergeant James Sides is the first recipient of its IMES System in an FDA study.
The IMES — implantable myoelectric sensor — System is an experimental system that could be the first minimally invasive, multi-channel control system for prosthetics intended for long term use.
The device is currently a part of an ongoing trial conducted by Alfred Mann Foundation with injured veterans at the Walter Reed National Medical Military Center in Bethesda, Md. The device is designed to provide up to three distinct movements that can occur simultaneously.
More Articles on Devices:
Johnson & Johnson to Dole Out $4B in Metal Hip Replacement Lawsuit Settlement
NLT Spine Receives FDA Clearance for Second Generation Spine Fusion Devices
Titan Spine Celebrates 18k Implantations of Interbody Fusion Device